Table 5

Review of studies evaluating impact of dialysis modality on kidney-transplant outcomes

Authors (year),* countryStudy designPatient noFollow-up periodPost-transplant outcomesFavourQuality†
Goldfarb-Rumyantzev et al (2005),41 USACohort, retrospective database92 844 patients from USRDS database10 years
(during 1990–1999)
PD was associated with shorter time on dialysis, better graft and patient survivalPDGood
Molnar et al (2011),40 USACohort, retrospective database14 508 recipients
(HD:12416, PD:2092)
6 years
(during 2001–2006)
PD with lower mortality rate, but no differences in DGF or death-censored graft survival after adjustmentPDFair
Schwenger et al (2011),42 GermanyCohort, multicentre57 315 recipients (HD: 45 651, PD: 11 664)Median 5 years
(during 1998–2007)
PD with lower all-cause mortality but similar graft survivalPDGood
Kramer et al (2012),39 the NetherlandsCohort, retrospective database29 088 adult recipients from 16 European renal registriesMedian 5 years
(during 1999–2008)
PD was associated with better patient and graft survivals, but no longer significant after instrumental variable analysisNonGood
López-Oliva et al (2013),12 SpainCohort, retrospective single-centre236 recipients (HD:118, PD:118)Median 8.5 years
(during 1990–2002)
PD has better long-term patient survival, but not graft survival in the multivariate analysisPDFair
Martins et al (2015),11 PortugalCohort, retrospective single centre158 recipients of pancreas-kidney transplantation (HD:119, PD:39)Median 5.9 years
(during 2000–2013)
PD with more intra-abdominal infection, leading to pancreas loss and renal thrombosis, with adverse impact on patient survivalHDFair
Dipalma et al (2016),14 SpainCohort, retrospective single centre180 donor-matched recipients (HD:80, PD:80)Median 73 months
(during 1990–2007)
No significant difference in death-censored graft survival and patient survival after propensity-score adjustmentNonGood
Tang et al (2016),13 ChinaMeta-analysis12 studies, excluded children, sample <100 ptsPD conferred less DGF, better 5-year patient survival, but not graft survivalPDFair
  • *The references are listed in the order of published year.

  • †Quality assessments were based on the Newcastle-Ottawa Scale for observational cohort studies and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses tool for systemic review/meta-analysis. All studies were rated as ‘good, fair or poor’ according to fulfilment of applied assessment checklist.

  • DGF, delayed graft function; HD, haemodialysis; PD, peritoneal dialysis; USRDS, United States Renal Data System.